Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis.

López-Mejías R, Carmona FD, Castañeda S, Genre F, Remuzgo-Martínez S, Sevilla-Perez B, Ortego-Centeno N, Llorca J, Ubilla B, Mijares V, Pina T, Miranda-Filloy JA, Navas Parejo A, de Argila D, Aragües M, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, Jayne D, Blanco R, Martín J, González-Gay MA.

Sci Rep. 2017 Jul 11;7(1):5088. doi: 10.1038/s41598-017-03915-2.

2.

Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients.

Alvarez Rivas N, Vazquez Rodriguez TR, Miranda Filloy JA, Garcia-Porrua C, Sanchez-Andrade Fernández A.

Reumatol Clin. 2017 May 25. pii: S1699-258X(17)30098-0. doi: 10.1016/j.reuma.2017.04.007. [Epub ahead of print] English, Spanish.

3.

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

López-Mejías R, Corrales A, Vicente E, Robustillo-Villarino M, González-Juanatey C, Llorca J, Genre F, Remuzgo-Martínez S, Dierssen-Sotos T, Miranda-Filloy JA, Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Ferraz-Amaro I, Gómez-Vaquero C, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Ocejo-Vinyals JG, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2017 Jan 6;7:40303. doi: 10.1038/srep40303.

4.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, González-Juanatey C, Robustillo-Villarino M, Llorca J, Corrales A, Vicente E, Miranda-Filloy JA, Magro C, Tejera-Segura B, Ramírez Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Mínguez Sánchez MD, Gómez-Vaquero C, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2016 Aug 18;6:31979. doi: 10.1038/srep31979.

5.

Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura.

López-Mejías R, Genre F, Remuzgo-Martínez S, Sevilla Pérez B, Castañeda S, Llorca J, Ortego-Centeno N, Ubilla B, Mijares V, Pina T, Calvo-Río V, Miranda-Filloy JA, Navas Parejo A, Argila D, Sánchez-Pérez J, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, Martín J, Blanco R, González-Gay MA.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S84-8. Epub 2016 Feb 1.

PMID:
26842496
6.

Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.

López-Mejías R, Genre F, Remuzgo-Martínez S, Robustillo-Villarino M, García-Bermúdez M, Llorca J, Corrales A, González-Juanatey C, Ubilla B, Miranda-Filloy JA, Mijares V, Pina T, Blanco R, Alegre-Sancho JJ, Ramírez Huaranga MA, Mínguez Sánchez MD, Tejera Segura B, Ferraz-Amaro I, Vicente E, Carmona FD, Castañeda S, Martín J, González-Gay MA.

PLoS One. 2015 Nov 16;10(11):e0143153. doi: 10.1371/journal.pone.0143153. eCollection 2015.

7.

Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis).

López-Mejías R, Genre F, Remuzgo-Martínez S, Pérez BS, Castañeda S, Llorca J, Ortego-Centeno N, Ubilla B, Mijares V, Pina T, Calvo-Río V, Palmou N, Miranda-Filloy JA, Parejo AN, Argila D, Sánchez-Pérez J, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, Ocejo-Vinyals JG, Martín J, Blanco R, González-Gay MA.

Arthritis Res Ther. 2015 Oct 13;17:286. doi: 10.1186/s13075-015-0796-x.

8.

Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.

Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Mijares V, Carnero-López B, Gómez-Acebo I, Dierssen-Sotos T, Remuzgo-Martínez S, Blanco R, Pina T, González-Juanatey C, Llorca J, González-Gay MA.

Rheumatol Int. 2015 Dec;35(12):2069-78. doi: 10.1007/s00296-015-3314-1. Epub 2015 Jul 5.

PMID:
26143161
9.

Association of HLA-B*41:02 with Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status.

López-Mejías R, Genre F, Pérez BS, Castañeda S, Ortego-Centeno N, Llorca J, Ubilla B, Remuzgo-Martínez S, Mijares V, Pina T, Calvo-Río V, Márquez A, Miranda-Filloy JA, Parejo AN, Conde-Jaldón M, Ortiz-Fernández L, Argila D, Aragües M, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, González Escribano F, Ocejo-Vinyals JG, Martín J, Blanco R, González-Gay MA.

Arthritis Res Ther. 2015 Apr 14;17:102. doi: 10.1186/s13075-015-0622-5.

10.

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Carmona FD, Mackie SL, Martín JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castañeda S, Cid MC, Hernández-Rodríguez J, Prieto-González S, Solans R, Ramentol-Sintas M, González-Escribano MF, Ortiz-Fernández L, Morado IC, Narváez J, Miranda-Filloy JA; Spanish GCA Group, Beretta L, Lunardi C, Cimmino MA, Gianfreda D, Santilli D, Ramirez GA, Soriano A, Muratore F, Pazzola G, Addimanda O, Wijmenga C, Witte T, Schirmer JH, Moosig F, Schönau V, Franke A, Palm Ø, Molberg Ø, Diamantopoulos AP, Carette S, Cuthbertson D, Forbess LJ, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Monach PA, Pagnoux C, Seo P, Spiera R, Sreih AG, Warrington KJ, Ytterberg SR, Gregersen PK, Pease CT, Gough A, Green M, Hordon L, Jarrett S, Watts R, Levy S, Patel Y, Kamath S, Dasgupta B, Worthington J, Koeleman BP, de Bakker PI, Barrett JH, Salvarani C, Merkel PA, González-Gay MA, Morgan AW, Martín J.

Am J Hum Genet. 2015 Apr 2;96(4):565-80. doi: 10.1016/j.ajhg.2015.02.009. Epub 2015 Mar 26.

11.

Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, Corrales A, Llorca J, González-Juanatey C, Ubilla B, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, Martín J, González-Gay MA.

Biomed Res Int. 2015;2015:318364. doi: 10.1155/2015/318364. Epub 2015 Mar 1.

12.

HLA-DRB1 association with Henoch-Schonlein purpura.

López-Mejías R, Genre F, Pérez BS, Castañeda S, Ortego-Centeno N, Llorca J, Ubilla B, Remuzgo-Martínez S, Mijares V, Pina T, Calvo-Río V, Márquez A, Sala-Icardo L, Miranda-Filloy JA, Conde-Jaldón M, Ortiz-Fernández L, Rubio E, León Luque M, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, González-Vela MC, Ocejo-Vinyals JG, González Escribano F, Martín J, Blanco R, González-Gay MA.

Arthritis Rheumatol. 2014 Dec 2. doi: 10.1002/art.38979. [Epub ahead of print]

13.

IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondylitis patients undergoing anti-TNF-alpha therapy.

Genre F, López-Mejías R, Rueda-Gotor J, Miranda-Filloy JA, Ubilla B, Villar-Bonet A, Carnero-López B, Gómez-Acebo I, Blanco R, Pina T, González-Juanatey C, Llorca J, González-Gay MA.

Biomed Res Int. 2014;2014:671061. doi: 10.1155/2014/671061. Epub 2014 Sep 11.

14.

Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.

Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Palmou-Fontana N, Gómez-Acebo I, Blanco R, Rueda-Gotor J, Pina T, González-Juanatey C, Llorca J, González-Gay MÁ.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):640-6. Epub 2014 Sep 5.

PMID:
25190453
15.

Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis.

Genre F, López-Mejías R, García-Bermúdez M, Castañeda S, González-Juanatey C, Llorca J, Corrales A, Ubilla B, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, González-Álvaro I, Martín J, González-Gay MA.

PLoS One. 2014 Sep 3;9(9):e106823. doi: 10.1371/journal.pone.0106823. eCollection 2014.

16.

Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, Llorca J, González-Juanatey C, Corrales A, Ubilla B, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, Martín J, González-Gay MA.

Arthritis Res Ther. 2014 Jul 10;16(4):R146. doi: 10.1186/ar4608.

17.

Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effect.

Genre F, López-Mejías R, Rueda-Gotor J, Miranda-Filloy JA, Ubilla B, Carnero-López B, Palmou-Fontana N, Gómez-Acebo I, Blanco R, Pina T, Ochoa R, González-Juanatey C, Llorca J, González-Gay MA.

Mediators Inflamm. 2014;2014:798060. doi: 10.1155/2014/798060. Epub 2014 May 21.

18.

Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis.

López-Mejías R, Genre F, Corrales A, González-Juanatey C, Ubilla B, Llorca J, Miranda-Filloy JA, Pina T, Blanco R, Castañeda S, Martín J, González-Gay MA.

Ann Rheum Dis. 2014 Sep;73(9):1749-50. doi: 10.1136/annrheumdis-2014-205543. Epub 2014 May 15. No abstract available.

PMID:
24833785
19.

Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis.

López-Mejías R, Genre F, García-Bermúdez M, Ubilla B, Castañeda S, Llorca J, González-Juanatey C, Corrales A, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, Martín J, González-Gay MA.

Mediators Inflamm. 2014;2014:756279. doi: 10.1155/2014/756279. Epub 2014 Mar 25.

20.

Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.

Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Blanco R, Pina T, González-Juanatey C, Llorca J, González-Gay MA.

Biomed Res Int. 2014;2014:860651. doi: 10.1155/2014/860651. Epub 2014 Mar 18. Review.

21.

Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis.

Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Morado IC, Rodriguez-Rodriguez L, Narváez J, Gómez-Vaquero C, Miranda-Filloy JA, Martínez-Taboada VM, Ríos R, Sopeña B, Monfort J, García-Villanueva MJ, Martínez-Zapico A, Marí-Alfonso B, Sánchez-Martín J, Unzurrunzaga A, Raya E, de Miguel E, Hidalgo-Conde A, Blanco R, González-Gay MÁ, Martín J; Spanish GCA Consortium.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S30-3. Epub 2014 Apr 7.

PMID:
24709033
22.

Lack of association between IL6 gene and Henoch-Schönlein purpura.

López-Mejías R, Sevilla Pérez B, Genre F, Castañeda S, Ortego-Centeno N, Miranda-Filloy JA, Llorca J, Martín J, Blanco R, González-Gay MA.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S141-2. Epub 2014 Feb 11. No abstract available.

PMID:
24528956
23.

No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and Henoch-Schönlein purpura.

López-Mejías R, Sevilla Pérez B, Genre F, Castañeda S, Ortego-Centeno N, Llorca J, Ubilla B, Ochoa R, Pina T, Marquez A, Sala-Icardo L, Miranda-Filloy JA, Rueda-Gotor J, Martín J, Blanco R, González-Gay MA.

Tissue Antigens. 2013 Dec;82(6):416-9. doi: 10.1111/tan.12251.

PMID:
24498998
24.

Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, González-Juanatey C, Llorca J, Corrales A, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Pascual-Salcedo D, Balsa A, López-Longo FJ, Carreira P, Blanco R, González-Álvaro I, Martín J, González-Gay MA.

Tissue Antigens. 2013 Dec;82(6):405-9. doi: 10.1111/tan.12227. Epub 2013 Oct 15.

PMID:
24498997
25.

Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis.

Dessein PH, López-Mejias R, González-Juanatey C, Genre F, Miranda-Filloy JA, Llorca J, González-Gay MA.

J Rheumatol. 2014 Mar;41(3):429-36. doi: 10.3899/jrheum.131037. Epub 2014 Feb 1.

PMID:
24488413
26.

Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy.

Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Gómez-Acebo I, Blanco R, Ochoa R, Rueda-Gotor J, González-Juanatey C, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):218-24. Epub 2013 Dec 16.

PMID:
24351434
27.

Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients.

Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Gómez-Acebo I, Blanco R, Ochoa R, Rueda-Gotor J, Pina T, González-Juanatey C, Llorca J, González-Gay MA.

Ann Rheum Dis. 2014 May;73(5):941-3. doi: 10.1136/annrheumdis-2013-204484. Epub 2013 Dec 9. No abstract available.

PMID:
24323393
28.

Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.

Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Gómez-Acebo I, Blanco R, Ochoa R, Arias-Bajo M, Rueda-Gotor J, Paz-Carreira J, González-Juanatey C, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):231-6. Epub 2013 Dec 2.

PMID:
24295386
29.

The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis.

López-Mejías R, Genre F, García-Bermúdez M, Corrales A, González-Juanatey C, Llorca J, Miranda-Filloy JA, Rueda-Gotor J, Blanco R, Castañeda S, Martín J, González-Gay MA.

Arthritis Res Ther. 2013 Oct 11;15(5):R152. doi: 10.1186/ar4335.

30.

SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, González-Juanatey C, Llorca J, Corrales A, Miranda-Filloy JA, Rueda-Gotor J, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Pascual-Salcedo D, Balsa A, López-Longo FJ, Carreira P, Blanco R, González-Álvaro I, Martín J, González-Gay MA.

PLoS One. 2013 Oct 21;8(10):e77695. doi: 10.1371/journal.pone.0077695. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/3fc037c1-2585-4d2b-a781-e04ab7b3bfeb.

31.

The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis.

López-Mejías R, Genre F, García-Bermúdez M, Castañeda S, González-Juanatey C, Llorca J, Corrales A, Miranda-Filloy JA, Rueda-Gotor J, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, González-Álvaro I, Martín J, González-Gay MA.

Tissue Antigens. 2013 Nov;82(5):344-7. doi: 10.1111/tan.12217.

PMID:
24131021
32.

Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy.

Genre F, López-Mejías R, Miranda-Filloy JA, Carnero-López B, Gómez-Acebo I, Blanco R, Ochoa R, Rueda J, González-Juanatey C, Llorca J, González-Gay MÁ.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):913-8. Epub 2013 Aug 26.

PMID:
23981480
33.

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

Serrano A, Márquez A, Mackie SL, Carmona FD, Solans R, Miranda-Filloy JA, Hernández-Rodríguez J, Cid MC, Castañeda S, Morado IC, Narváez J, Blanco R, Sopeña B, García-Villanueva MJ, Monfort J, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez Martín J, de Miguel E, Magro C, Raya E; UK GCA Consortium; Spanish GCA Consortium, Braun N, Latus J, Molberg O, Lie BA, Moosig F, Witte T, Morgan AW, González-Gay MA, Martín J.

Ann Rheum Dis. 2013 Nov;72(11):1882-1886. doi: 10.1136/annrheumdis-2013-203641. Epub 2013 Aug 14.

34.

Sex differences in patients with systemic lupus erythematosus from Northwest Spain.

Alonso MD, Martínez-Vázquez F, Riancho-Zarrabeitia L, Díaz de Terán T, Miranda-Filloy JA, Blanco R, González-Juanatey C, Llorca J, González-Gay MA.

Rheumatol Int. 2014 Jan;34(1):11-24. doi: 10.1007/s00296-013-2798-9. Epub 2013 Jun 28.

PMID:
23812032
35.

Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.

Genre F, López-Mejías R, Miranda-Filloy JA, Carnero-López B, Gómez-Acebo I, Blanco R, Ochoa R, Rueda J, González-Juanatey C, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):749-55. Epub 2013 Jun 14.

PMID:
23806325
36.

Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.

Miranda-Filloy JA, López-Mejias R, Genre F, Carnero-López B, Ochoa R, Diaz de Terán T, González-Juanatey C, Blanco R, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4):538-45. Epub 2013 May 27.

PMID:
23711190
37.

Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.

Genre F, Miranda-Filloy JA, López-Mejias R, Carnero-López B, Ochoa R, Rueda J, González-Juanatey C, Blanco R, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4):532-7. Epub 2013 Mar 13.

PMID:
23484462
38.

Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients.

Genre F, Miranda-Filloy JA, López-Mejias R, Carnero-López B, Ochoa R, Rueda J, González-Juanatey C, Blanco R, Llorca J, González-Gay MA.

Ann Rheum Dis. 2013 Jul;72(7):1265-7. doi: 10.1136/annrheumdis-2012-203169. Epub 2013 Mar 12. No abstract available.

PMID:
23482472
39.

Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis.

Gonzalez-Gay MA, Garcia-Porrua C, Gonzalez-Juanatey C, Miranda-Filloy JA, Blanco R, Llorca J.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S94. Epub 2013 Mar 4. No abstract available.

PMID:
23463922
40.

A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis.

Serrano A, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Gomez-Vaquero C, Solans R, Sopeña B, Blanco R, Unzurrunzaga A, Ortego-Centeno N, Marí-Alfonso B, Hidalgo-Conde A, Hernández-Rodríguez J, Cid MC, Martín J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S5-8. Epub 2013 Jan 7.

PMID:
23306142
41.

Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.

Miranda-Filloy JA, López-Mejias R, Genre F, Carnero-López B, Ochoa R, Diaz de Terán T, González-Juanatey C, Blanco R, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2013 May-Jun;31(3):365-71. Epub 2013 Jan 23.

PMID:
23294554
42.

Evidence of association of the NLRP1 gene with giant cell arteritis.

Serrano A, Carmona FD, Castañeda S, Solans R, Hernández-Rodríguez J, Cid MC, Prieto-González S, Miranda-Filloy JA, Rodríguez-Rodríguez L, Morado IC, Gomez-Vaquero C, Blanco R, Sopeña B, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez-Martín J, García-Villanueva MJ, Hidalgo-Conde A, Pazzola G, Boiardi L, Salvarani C, González-Gay MA, Martín J.

Ann Rheum Dis. 2013 Apr;72(4):628-30. doi: 10.1136/annrheumdis-2012-202609. Epub 2012 Dec 19. No abstract available.

43.

Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.

García-Bermúdez M, González-Juanatey C, López-Mejías R, Teruel M, Corrales A, Miranda-Filloy JA, Castañeda S, Balsa A, Fernández-Gutierrez B, González-Álvaro I, Gómez-Vaquero C, Blanco R, Llorca J, Martín J, González-Gay MA.

PLoS One. 2012;7(11):e49214. doi: 10.1371/journal.pone.0049214. Epub 2012 Nov 15.

44.

Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy.

González-Gay MA, González-Juanatey C, Miranda-Filloy JA, García-Unzueta MT, Llorca J.

Acta Reumatol Port. 2012 Apr-Jun;37(2):155-9.

PMID:
23149638
45.

CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients.

García-Bermúdez M, López-Mejías R, González-Juanatey C, Corrales A, Castañeda S, Ortiz AM, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, Llorca J, Martín J, González-Gay MA.

DNA Cell Biol. 2013 Jan;32(1):28-33. doi: 10.1089/dna.2012.1836. Epub 2012 Oct 22.

46.

Analysis of the interferon gamma (rs2430561, +874T/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, González-Juanatey C, Corrales A, Robledo G, Castañeda S, Miranda-Filloy JA, Blanco R, Fernández-Gutiérrez B, Balsa A, González-Alvaro I, Gómez-Vaquero C, Llorca J, Martín J, González-Gay MA.

PLoS One. 2012;7(10):e47166. doi: 10.1371/journal.pone.0047166. Epub 2012 Oct 15.

47.

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy.

Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gomez-Acebo I, Testa A, Garcia-Porrua C, Sanchez-Andrade A, Llorca J, González-Gay MA.

Mediators Inflamm. 2012;2012:674265. doi: 10.1155/2012/674265. Epub 2012 Jul 31.

48.

TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients.

Miranda-Filloy JA, Llorca J, Carnero-López B, González-Juanatey C, Blanco R, González-Gay MA.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):850-5. Epub 2012 Dec 17.

PMID:
22765845
49.

NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis.

López-Mejías R, García-Bermúdez M, González-Juanatey C, Castañeda S, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, González-Álvaro I, Llorca J, Martín J, González-Gay MA.

Atherosclerosis. 2012 Oct;224(2):426-9. doi: 10.1016/j.atherosclerosis.2012.06.008. Epub 2012 Jun 13.

PMID:
22742859
50.

Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, González-Juanatey C, Castañeda S, Miranda-Filloy JA, Blanco R, Fernández-Gutiérrez B, Balsa A, González-Álvaro I, Gómez-Vaquero C, Llorca J, Martín J, González-Gay MA.

Scand J Rheumatol. 2012 Oct;41(5):350-3. doi: 10.3109/03009742.2012.677063. Epub 2012 Jun 3.

PMID:
22657383

Supplemental Content

Loading ...
Support Center